PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma. Yi J, Kim B, Shi X, Zhan X, et al. Cancer Res 2022 Jun 22. pii: 705063. doi: 10.1158/0008-5472.CAN-21-4313.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yi J, Kim B, Shi X, Zhan X, et al. PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma. Cancer Res 2022 Jun 22. pii: 705063. doi: 10.1158/0008-5472.CAN-21-4313.
PMID: 35731926